Tandem Diabetes Care (TNDM) Competitors $17.71 +0.68 (+3.99%) Closing price 04/15/2025 04:00 PM EasternExtended Trading$17.71 0.00 (0.00%) As of 04/15/2025 06:06 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock TNDM vs. INSP, BLCO, SLNO, IRTC, PRCT, NVST, TMDX, LIVN, ENOV, and NVCRShould you be buying Tandem Diabetes Care stock or one of its competitors? The main competitors of Tandem Diabetes Care include Inspire Medical Systems (INSP), Bausch + Lomb (BLCO), Soleno Therapeutics (SLNO), iRhythm Technologies (IRTC), PROCEPT BioRobotics (PRCT), Envista (NVST), TransMedics Group (TMDX), LivaNova (LIVN), Enovis (ENOV), and NovoCure (NVCR). These companies are all part of the "medical equipment" industry. Tandem Diabetes Care vs. Inspire Medical Systems Bausch + Lomb Soleno Therapeutics iRhythm Technologies PROCEPT BioRobotics Envista TransMedics Group LivaNova Enovis NovoCure Inspire Medical Systems (NYSE:INSP) and Tandem Diabetes Care (NASDAQ:TNDM) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, earnings, dividends, community ranking, profitability, institutional ownership, risk, analyst recommendations and valuation. Is INSP or TNDM more profitable? Inspire Medical Systems has a net margin of 6.67% compared to Tandem Diabetes Care's net margin of -14.84%. Inspire Medical Systems' return on equity of 8.19% beat Tandem Diabetes Care's return on equity.Company Net Margins Return on Equity Return on Assets Inspire Medical Systems6.67% 8.19% 7.09% Tandem Diabetes Care -14.84%-44.19%-11.99% Does the MarketBeat Community believe in INSP or TNDM? Tandem Diabetes Care received 393 more outperform votes than Inspire Medical Systems when rated by MarketBeat users. However, 61.78% of users gave Inspire Medical Systems an outperform vote while only 60.89% of users gave Tandem Diabetes Care an outperform vote. CompanyUnderperformOutperformInspire Medical SystemsOutperform Votes19461.78% Underperform Votes12038.22% Tandem Diabetes CareOutperform Votes58760.89% Underperform Votes37739.11% Does the media prefer INSP or TNDM? In the previous week, Tandem Diabetes Care had 7 more articles in the media than Inspire Medical Systems. MarketBeat recorded 22 mentions for Tandem Diabetes Care and 15 mentions for Inspire Medical Systems. Inspire Medical Systems' average media sentiment score of 1.66 beat Tandem Diabetes Care's score of 1.28 indicating that Inspire Medical Systems is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Inspire Medical Systems 13 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Very Positive Tandem Diabetes Care 13 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals and insiders believe in INSP or TNDM? 94.9% of Inspire Medical Systems shares are owned by institutional investors. 4.1% of Inspire Medical Systems shares are owned by insiders. Comparatively, 2.2% of Tandem Diabetes Care shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Which has stronger valuation and earnings, INSP or TNDM? Inspire Medical Systems has higher earnings, but lower revenue than Tandem Diabetes Care. Tandem Diabetes Care is trading at a lower price-to-earnings ratio than Inspire Medical Systems, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInspire Medical Systems$802.80M5.43$53.51M$1.7384.73Tandem Diabetes Care$940.20M1.25-$222.61M-$1.46-12.13 Which has more risk and volatility, INSP or TNDM? Inspire Medical Systems has a beta of 1.39, meaning that its share price is 39% more volatile than the S&P 500. Comparatively, Tandem Diabetes Care has a beta of 1.52, meaning that its share price is 52% more volatile than the S&P 500. Do analysts recommend INSP or TNDM? Inspire Medical Systems presently has a consensus target price of $222.20, suggesting a potential upside of 51.58%. Tandem Diabetes Care has a consensus target price of $43.88, suggesting a potential upside of 147.78%. Given Tandem Diabetes Care's higher probable upside, analysts plainly believe Tandem Diabetes Care is more favorable than Inspire Medical Systems.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Inspire Medical Systems 0 Sell rating(s) 3 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.70Tandem Diabetes Care 0 Sell rating(s) 8 Hold rating(s) 11 Buy rating(s) 0 Strong Buy rating(s) 2.58 SummaryInspire Medical Systems beats Tandem Diabetes Care on 12 of the 18 factors compared between the two stocks. Remove Ads Get Tandem Diabetes Care News Delivered to You Automatically Sign up to receive the latest news and ratings for TNDM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TNDM vs. The Competition Export to ExcelMetricTandem Diabetes CareSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.18B$4.09B$5.33B$7.57BDividend YieldN/A39.50%5.11%4.33%P/E Ratio-9.1828.0221.8317.81Price / Sales1.2547.80379.4694.58Price / CashN/A51.0838.1534.64Price / Book3.685.826.454.00Net Income-$222.61M$67.09M$3.20B$247.23M7 Day Performance8.19%5.59%6.60%7.26%1 Month Performance-7.62%-3.25%-8.50%-6.26%1 Year Performance-44.41%14.72%10.33%-0.18% Tandem Diabetes Care Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TNDMTandem Diabetes Care4.2123 of 5 stars$17.71+4.0%$43.88+147.8%-44.4%$1.13B$940.20M-9.182,600News CoveragePositive NewsGap DownINSPInspire Medical Systems4.6381 of 5 stars$149.72+5.5%$226.70+51.4%-34.3%$4.46B$802.80M86.541,246Analyst ForecastNews CoveragePositive NewsGap UpBLCOBausch + Lomb3.8719 of 5 stars$11.86-2.1%$18.82+58.7%-16.5%$4.18B$4.79B-13.0312,500Gap DownSLNOSoleno Therapeutics4.7804 of 5 stars$69.16+2.5%$99.63+44.0%+82.4%$3.17BN/A-20.8330Analyst ForecastGap DownHigh Trading VolumeIRTCiRhythm Technologies0.9177 of 5 stars$100.290.0%$119.73+19.4%-8.0%$3.15B$591.84M-27.551,790Positive NewsPRCTPROCEPT BioRobotics2.3993 of 5 stars$50.84-0.8%$94.29+85.5%+4.6%$2.79B$224.50M-26.07430Positive NewsGap DownNVSTEnvista4.3811 of 5 stars$15.27-1.4%$20.18+32.2%-21.0%$2.63B$2.51B-2.3512,700Analyst ForecastAnalyst RevisionNews CoveragePositive NewsGap DownTMDXTransMedics Group2.7688 of 5 stars$68.99+1.9%$122.70+77.9%-5.1%$2.32B$441.54M73.39210LIVNLivaNova3.555 of 5 stars$35.43-1.5%$61.17+72.7%-34.8%$1.93B$1.25B84.352,900News CoveragePositive NewsGap DownENOVEnovis2.2051 of 5 stars$32.41-0.4%$58.50+80.5%-44.7%$1.85B$2.11B-14.806,800Gap DownNVCRNovoCure3.3286 of 5 stars$16.62+0.8%$35.80+115.4%+29.4%$1.83B$605.22M-11.871,320 Remove Ads Related Companies and Tools Related Companies INSP Alternatives BLCO Alternatives SLNO Alternatives IRTC Alternatives PRCT Alternatives NVST Alternatives TMDX Alternatives LIVN Alternatives ENOV Alternatives NVCR Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TNDM) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTariffs. Volatility. Fear. Here’s the Plan.Wall Street's panicking over tariffs. Volatility's back with a vengeance. If you've been glued to the he...Investors Alley | SponsoredThis story is about to go viralThis Story Could Go Viral as Soon as May 31 Quietly, towns like Shreveport, Louisiana and Fort Worth, Texas...Stansberry Research | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tandem Diabetes Care, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tandem Diabetes Care With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.